SUBSTRATE SPECIFICITY OF ANTINUCLEAR ANTIBODIES IN SCLERODERMA
- 1 April 1977
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 68 (4), 191-193
- https://doi.org/10.1111/1523-1747.ep12492668
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ANTI-NUCLEAR FACTORS IN HEPATIC CIRRHOSISActa Pathologica Microbiologica Scandinavica, 2009
- FIELD TRIALS BY TEN LABORATORIES OF SIX COMMERCIAL CONJUGATES PREPARED FROM ANTISERA TO HUMAN IgGAnnals of the New York Academy of Sciences, 1971
- ANTINUCLEAR-FACTOR SERUM (HOMOGENEOUS): AN INTERNATIONAL COLLABORATIVE STUDY OF THE PROPOSED RESEARCH STANDARD 66/233Annals of the New York Academy of Sciences, 1971
- Immunologic and clinical observations of granulocyte‐specific antinuclear antibodiesArthritis & Rheumatism, 1969
- Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1968
- Granulocyte-specific antinuclear factors in serum and synovial fluid in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1968
- The clinical significance of titered antinuclear antibodiesArthritis & Rheumatism, 1967
- STUDIES ON ANTINUCLEAR ANTIBODIESAnnals of the New York Academy of Sciences, 1965
- ANTINUCLEAR AND PRECIPITATING AUTOANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSISThe Lancet, 1963
- A Clinical Study of Serum Antinuclear FactorBMJ, 1961